Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2025)

Tarsus Pharmaceuticals (TARS) has 4 years of Interest Coverage Ratio data on record, last reported at 3.6 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 65.89% year-over-year to 3.6; the TTM value through Dec 2025 reached 7.94, up 48.29%, while the annual FY2025 figure was 7.94, 48.29% up from the prior year.
  • Interest Coverage Ratio reached 3.6 in Q4 2025 per TARS's latest filing, up from 6.41 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 3.6 in Q4 2025 and bottomed at 61.78 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 25.33, with a median of 18.78 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: crashed 330.16% in 2023, then skyrocketed 78.43% in 2024.
  • A 4-year view of Interest Coverage Ratio shows it stood at 21.76 in 2022, then plummeted by 106.5% to 44.94 in 2023, then soared by 76.5% to 10.56 in 2024, then skyrocketed by 65.89% to 3.6 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 3.6 in Q4 2025, 6.41 in Q3 2025, and 9.9 in Q2 2025.